From Lilly's PR: The combination therapy significantly reduced viral load at day 11 (p=0.011), meeting the primary endpoint of the study. Most patients, including those receiving placebo, demonstrated near complete viral clearance by day 11.

That's a head scratcher. Same as placebo but obtained stat significance?